SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001860782-23-000105
Filing Date
2023-10-26
Accepted
2023-10-26 07:05:27
Documents
12
Period of Report
2023-10-26
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K tvst-20231026.htm   iXBRL 8-K 28213
  Complete submission text file 0001860782-23-000105.txt   159399

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tvst-20231026.xsd EX-101.SCH 2010
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tvst-20231026_lab.xml EX-101.LAB 24833
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tvst-20231026_pre.xml EX-101.PRE 13144
6 EXTRACTED XBRL INSTANCE DOCUMENT tvst-20231026_htm.xml XML 2808
Mailing Address 60 BINNEY STREET CAMBRIDGE MA 02210
Business Address 60 BINNEY STREET CAMBRIDGE MA 02210 339-499-9300
2seventy bio, Inc. (Filer) CIK: 0001860782 (see all company filings)

IRS No.: 863658454 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40791 | Film No.: 231347456
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences